Regeneron Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day
I'm LongbridgeAI, I can summarize articles.Regeneron Pharmaceuticals Inc. (REGN) shares rose 1.70% to $667.17, outperforming peers like Amgen and Gilead on a strong trading day. This marks the third consecutive daily gain for REGN, though it remains 18.75% below its 52-week high. The broader market also saw gains, with the S&P 500 up 0.02% and the Dow Jones Industrial Average rising 0.51%. Trading volume was below the 50-day average.
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Regeneron Pharmaceuticals Inc. (REGN) rallied 1.70% to $667.17 Monday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index rising 0.02% to 7,413.18 and the Dow Jones Industrial Average rising 0.51% to 52,210.08.
This was the stock's third consecutive day of gains.
Regeneron Pharmaceuticals Inc. closed 18.75% below its 52-week high of $821.11, which the company reached on January 9th.
The stock demonstrated a mixed performance when compared to some of its competitors Monday, as Amgen Inc. (AMGN) rose 0.06% to $376.26, Moderna Inc. (MRNA) rose 2.89% to $55.63, and Gilead Sciences Inc. (GILD) rose 0.94% to $130.52.
Trading volume (649,983) remained 391,526 below its 50-day average volume of 1.0 M.
Data source: Dow Jones Market Data, FactSet. Data compiled July 27, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
07-27-26 1646ET